Clinical Trial Update: Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina [Phase 2]

View source ↗

Summary

A multi-center Phase II trial evaluating T89 for chronic stable angina has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• T89

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Angina Pectoris | Phase 2 | Status: COMPLETED